Benoquin Cream – 30 Gm

Benoquin Cream – 30 Gm

Benoquin Cream – 30 Gm is a depigmenting agent used in the treatment of vitiligo, a skin condition characterized by loss of pigmentation. It contains monobenzone, which works by permanently depigmenting the remaining normal skin to achieve an even skin tone. This therapy is generally considered in extensive vitiligo cases where repigmentation treatments are not effective. The goal of treatment is cosmetic uniformity rather than restoration of natural pigment. In dermatological care, supportive treatments such as Betnovate – N may be used for inflammatory skin conditions, while antifungal agents like Eberconazole 1% – Ebernet are prescribed when fungal infections coexist or require management.

Mechanism of Action

Melanocyte Destruction

Benoquin Cream works by permanently destroying melanocytes, the cells responsible for producing melanin (skin pigment).

Depigmentation Effect

This results in gradual lightening of the skin, helping achieve a uniform appearance in patients with widespread vitiligo. For clinical insights, refer to American Academy of Dermatology (AAD) and for safety guidance, consult Mayo Clinic – Monobenzone Information.

Medical Uses

Benoquin Cream – 30 Gm is used for:

• Treatment of extensive vitiligo
• Permanent depigmentation therapy
• Cosmetic skin tone uniformity

It is not intended for minor pigmentation issues or cosmetic lightening.

Dosage and Administration

Benoquin Cream should be applied as directed by a dermatologist, usually once or twice daily to the pigmented areas of the skin. Treatment is gradual and may take several months to achieve desired results. In clinical practice, Betnovate – N may be used for associated inflammatory conditions, while Eberconazole 1% – Ebernet can be considered if fungal infections are present during treatment.

Clinical Effectiveness

Clinical experience shows that monobenzone can effectively achieve uniform depigmentation in patients with extensive vitiligo when used consistently under medical supervision.

Safety and Side Effects

Common Side Effects

• Skin irritation
• Redness
• Dryness
• Burning sensation

Serious Risks

• Permanent depigmentation
• Increased sensitivity to sunlight
• Risk of uneven skin lightening

Strict sun protection is essential during and after treatment. For more details, refer to Mayo Clinic – Monobenzone Information.

Contraindications and Precautions

Benoquin Cream – 30 Gm should not be used in:

• Patients with localized vitiligo
• Individuals seeking temporary skin lightening
• Patients with hypersensitivity to monobenzone

A dermatologist should evaluate the patient before starting therapy.

Drug Interactions

Benoquin Cream has minimal systemic absorption, but patients should inform their healthcare provider about all topical or systemic medications being used. For further reading, refer to American Academy of Dermatology (AAD).

FAQs